177 related articles for article (PubMed ID: 7678643)
1. Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
Bi W; Rao JY; Hemstreet GP; Fang P; Asal NR; Zang M; Min KW; Ma Z; Lee E; Li G
J Occup Med; 1993 Jan; 35(1):20-7. PubMed ID: 7678643
[TBL] [Abstract][Full Text] [Related]
2. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.
Rothman N; Hayes RB; Zenser TV; DeMarini DM; Bi W; Hirvonen A; Talaska G; Bhatnagar VK; Caporaso NE; Brooks LR; Lakshmi VM; Feng P; Kashyap SK; You X; Eischen BT; Kashyap R; Shelton ML; Hsu FF; Jaeger M; Parikh DJ; Davis BB; Yin S; Bell DA
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):979-83. PubMed ID: 8959320
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in the N-acetyltransferase 1 alleles NAT1*10 and NAT1*14A and cytological gradings of exfoliated urothelial cells in benzidine-exposed Chinese workers: discussion of ethnic differences.
Guo WC; Lin GF; Chen JG; Golka K; Shen JH
Arch Toxicol; 2004 Aug; 78(8):425-9. PubMed ID: 15197537
[TBL] [Abstract][Full Text] [Related]
4. The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening.
Marsh GM; Cassidy LD
Am J Ind Med; 2003 Feb; 43(2):142-8. PubMed ID: 12541268
[TBL] [Abstract][Full Text] [Related]
5. Early results of bladder-cancer screening in a high-risk population of heavy smokers.
Steiner H; Bergmeister M; Verdorfer I; Granig T; Mikuz G; Bartsch G; Stoehr B; Brunner A
BJU Int; 2008 Aug; 102(3):291-6. PubMed ID: 18336612
[TBL] [Abstract][Full Text] [Related]
6. Quantitative fluorescence image analysis in bladder cancer screening.
Hemstreet GP; Hurst RE; Bass RA; Rao JY
J Occup Med; 1990 Sep; 32(9):822-8. PubMed ID: 2074505
[TBL] [Abstract][Full Text] [Related]
7. Bladder cancer screening and monitoring of 4,4'-methylenebis(2-chloroaniline) exposure among workers in Taiwan.
Chen HI; Liou SH; Loh CH; Uang SN; Yu YC; Shih TS
Urology; 2005 Aug; 66(2):305-10. PubMed ID: 16098360
[TBL] [Abstract][Full Text] [Related]
8. [Occupational bladder tumors among persons subjected to carcinogenic amino compound exposure: the epidemiology and prevention].
Bul'bulian MA
Urol Nefrol (Mosk); 1991; (4):12-8. PubMed ID: 1949409
[TBL] [Abstract][Full Text] [Related]
9. Cancer mortality and incidence among a cohort of benzidine and dichlorobenzidine dye manufacturing workers.
Rosenman KD; Reilly MJ
Am J Ind Med; 2004 Nov; 46(5):505-12. PubMed ID: 15490466
[TBL] [Abstract][Full Text] [Related]
10. [A cohort study on the cancer experience among workers exposed to benzidine-derived dyes in Shanghai leather-tanning industry].
Chen JG
Zhonghua Yu Fang Yi Xue Za Zhi; 1990 Nov; 24(6):328-31. PubMed ID: 2099267
[TBL] [Abstract][Full Text] [Related]
11. G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials.
Hemstreet GP; Rao J; Hurst RE; Bonner RB; Waliszewski P; Grossman HB; Liebert M; Bane BL
J Cell Biochem Suppl; 1996; 25():197-204. PubMed ID: 9027619
[TBL] [Abstract][Full Text] [Related]
12. Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine.
Hemstreet GP; Yin S; Ma Z; Bonner RB; Bi W; Rao JY; Zang M; Zheng Q; Bane B; Asal N; Li G; Feng P; Hurst RE; Wang W
J Natl Cancer Inst; 2001 Mar; 93(6):427-36. PubMed ID: 11259468
[TBL] [Abstract][Full Text] [Related]
13. Bladder cancer among chemical workers exposed to nitrogen products and other substances.
Marsh GM; Gula MJ; Youk AO; Cassidy LD
Am J Ind Med; 2002 Oct; 42(4):286-95. PubMed ID: 12271476
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
16. Cellular F-actin levels as a marker for cellular transformation: correlation with bladder cancer risk.
Rao JY; Hemstreet GP; Hurst RE; Bonner RB; Min KW; Jones PL
Cancer Res; 1991 Jun; 51(11):2762-7. PubMed ID: 2032215
[TBL] [Abstract][Full Text] [Related]
17. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
18. [Occupational cancer of the urinary bladder: the diagnostic value of urinary cytology in dyestuff workers exposed to aromatic amines].
Matsushima M
Hinyokika Kiyo; 1989 Dec; 35(12):2033-40. PubMed ID: 2618902
[TBL] [Abstract][Full Text] [Related]
19. Cytologic detection of urothelial cancer and other abnormalities in a cohort of workers exposed to aromatic amines.
Crosby JH; Allsbrook WC; Koss LG; Bales CE; Witherington R; Schulte PA; Hemstreet G; Ringer K
Acta Cytol; 1991; 35(3):263-8. PubMed ID: 2042428
[TBL] [Abstract][Full Text] [Related]
20. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China.
Qiao YL; Tockman MS; Li L; Erozan YS; Yao SX; Barrett MJ; Zhou WH; Giffen CA; Luo XC; Taylor PR
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):893-900. PubMed ID: 9367062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
